Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, on Tuesday lowered its full-year earnings forecasts again as it unveiled a new chief ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its 2025-26 budget plans.

The terms “Ozempic face” and “Ozempic butt” are not truly side effects of GLP-1 drugs, but rather consequences that occur from rapid weight loss from the face and rear end.